The Department of Defense (DOD) is offering the Tuberous Sclerosis Complex (TSC) Research Program Clinical Trial Award. This grant specifically supports clinical trials, including pilot and Phase 0, I, or II studies, focused on Tuberous Sclerosis Complex. The primary objective is to fund research with the potential to significantly impact the treatment or management strategies for TSC. Applicants should note that funding from this award mechanism is strictly for clinical trial activities and cannot be utilized for preclinical research studies. This initiative aims to advance direct patient-focused interventions for TSC.
Opportunity ID: 158033
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-TSCRP-CTA |
| Funding Opportunity Title: | DOD FY12 Tuberous Sclerosis Complex Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 22, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 31, 2012 |
| Current Closing Date for Applications: | May 31, 2012 |
| Archive Date: | Jun 30, 2012 |
| Estimated Total Program Funding: | $1,600,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The Tuberous Sclerosis Complex (TSC) Research Program Clinical Trial Award supports pilot and Phase 0, I, or II clinical trials with the potential to have a major impact on the treatment or management of TSC. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP and eReceipt HELP: 301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 158033 Full Announcement-1 -> tscrp_fy12 cta_gg.pdf
Folder 158033 Full Announcement-1 -> fy12 tscrp_cta ind documentation form_gg.pdf
Packages
| Agency Contact Information: | PA HELP and eReceipt HELP: 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00110270 | Mar 22, 2012 | May 31, 2012 | View |
Package 1
Mandatory forms
158033 RR_SF424_1_2-1.2.pdf
158033 PerformanceSite_1_4-1.4.pdf
158033 RR_Budget-1.1.pdf
158033 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
158033 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
